AWH Aspira Women's Health Inc

Price (delayed)

$0.5144

Market cap

$57.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.31

Enterprise value

$34.4M

Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.

Highlights
AWH's gross profit has surged by 141% year-on-year and by 12% since the previous quarter
The company's gross margin has surged by 65% YoY and by 5% QoQ
The net income has dropped by 74% year-on-year and by 11% since the previous quarter
The EPS has plunged by 63% YoY and by 11% from the previous quarter

Key stats

What are the main financial stats of AWH
Market
Shares outstanding
112.21M
Market cap
$57.72M
Enterprise value
$34.4M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.65
Price to sales (P/S)
8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.77
Earnings
Revenue
$7.21M
EBIT
-$34.97M
EBITDA
-$34.67M
Free cash flow
-$32.54M
Per share
EPS
-$0.31
Free cash flow per share
-$0.29
Book value per share
$0.19
Revenue per share
$0.06
TBVPS
$0.28
Balance sheet
Total assets
$30.86M
Total liabilities
$9.12M
Debt
$3.78M
Equity
$21.74M
Working capital
$23.66M
Liquidity
Debt to equity
0.17
Current ratio
4.85
Quick ratio
4.6
Net debt/EBITDA
0.67
Margins
EBITDA margin
-480.9%
Gross margin
47.4%
Net margin
-485.6%
Operating margin
-498.8%
Efficiency
Return on assets
-79.7%
Return on equity
-102%
Return on invested capital
-7,266.1%
Return on capital employed
-141.4%
Return on sales
-485.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AWH stock price

How has the Aspira Women's Health stock price performed over time
Intraday
-0.31%
1 week
-10.97%
1 month
13.58%
1 year
-91.28%
YTD
-70.94%
QTD
-50.54%

Financial performance

How have Aspira Women's Health's revenue and profit performed over time
Revenue
$7.21M
Gross profit
$3.42M
Operating income
-$35.96M
Net income
-$35.01M
Gross margin
47.4%
Net margin
-485.6%
AWH's gross profit has surged by 141% year-on-year and by 12% since the previous quarter
The operating income has dropped by 79% year-on-year and by 10% since the previous quarter
The net income has dropped by 74% year-on-year and by 11% since the previous quarter
The company's gross margin has surged by 65% YoY and by 5% QoQ

Growth

What is Aspira Women's Health's growth rate over time

Valuation

What is Aspira Women's Health stock price valuation
P/E
N/A
P/B
2.65
P/S
8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.77
The EPS has plunged by 63% YoY and by 11% from the previous quarter
The stock's P/B is 87% below its 5-year quarterly average of 20.2 and 70% below its last 4 quarters average of 8.7
The company's equity has shrunk by 58% YoY and by 28% QoQ
AWH's price to sales (P/S) is 85% less than its last 4 quarters average of 51.8 and 83% less than its 5-year quarterly average of 45.9
Aspira Women's Health's revenue has increased by 46% YoY and by 6% from the previous quarter

Efficiency

How efficient is Aspira Women's Health business performance
The ROE has decreased by 35% from the previous quarter and by 6% YoY
The ROA has contracted by 30% from the previous quarter and by 15% YoY
Aspira Women's Health's ROIC has decreased by 27% from the previous quarter
The ROS has contracted by 19% YoY and by 4.5% from the previous quarter

Dividends

What is AWH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Recent dividends

Financial health

How did Aspira Women's Health financials performed over time
The company's quick ratio has shrunk by 53% YoY and by 6% QoQ
The company's current ratio has shrunk by 51% YoY and by 4.9% QoQ
The debt is 83% smaller than the equity
Aspira Women's Health's debt to equity has soared by 89% YoY and by 21% from the previous quarter
The company's equity has shrunk by 58% YoY and by 28% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.